Skip to Main Content

Author Details

Tim H-M Huang
University of Texas Health San Antonio (UTHSA)
1997
291
76
PMIDPaper TitleJournal TitlePublished Year
36583228KLRF1, a novel marker of CD56<sup>bright</sup> NK cells, predicts improved survival for patients with locally advanced bladder cancer.Cancer Med2023
37129868Targeting hepatic serine-arginine protein kinase 2 ameliorates alcohol-associated liver disease by alternative splicing control of lipogenesis.Hepatology2023
34624439Cellular junction and mesenchymal factors delineate an endometriosis-specific response of endometrial stromal cells to the mesothelium.Mol Cell Endocrinol2022
35394046Phosphorylated MED1 links transcription recycling and cancer growth.Nucleic Acids Res2022
35385705Deadenylase-dependent mRNA decay of GDF15 and FGF21 orchestrates food intake and energy expenditure.Cell Metab2022
36222718PRC2-Mediated Epigenetic Suppression of Type I IFN-STAT2 Signaling Impairs Antitumor Immunity in Luminal Breast Cancer.Cancer Res2022
35950923A First-in-Class Inhibitor of ER Coregulator PELP1 Targets ER+ Breast Cancer.Cancer Res2022
34997546Single-cell RNA profiling identifies diverse cellular responses to EWSR1/FLI1 downregulation in Ewing sarcoma cells.Cell Oncol (Dordr)2022
350210812-Hydroxyglutarate destabilizes chromatin regulatory landscape and lineage fidelity to promote cellular heterogeneity.Cell Rep2022
34610962GLI3 Is Stabilized by SPOP Mutations and Promotes Castration Resistance via Functional Cooperation with Androgen Receptor in Prostate Cancer.Mol Cancer Res2022
34662279Construction and Evaluation of Robust Interpretation Models for Breast Cancer Metastasis Prediction.IEEE/ACM Trans Comput Biol Bioinform2022
34322662Toward uncharted territory of cellular heterogeneity: advances and applications of single-cell RNA-seq.J Transl Genet Genom2021
34942100FOXP3 Is an X-Linked Breast Cancer Suppressor Gene and an Important Repressor of the HER-2/ErbB2 Oncogene.Cell2021
34496133Bladder tumor ILC1s undergo Th17-like differentiation in human bladder cancer.Cancer Med2021
34045187Contacts with Macrophages Promote an Aggressive Nanomechanical Phenotype of Circulating Tumor Cells in Prostate Cancer.Cancer Res2021
32424275Enhancer reprogramming driven by high-order assemblies of transcription factors promotes phenotypic plasticity and breast cancer endocrine resistance.Nat Cell Biol2020
31909204Attenuation of NAD[P]H:quinone oxidoreductase 1 aggravates prostate cancer and tumor cell plasticity through enhanced TGFβ signaling.Commun Biol2020
31992541Single-Cell Proteomic Profiling Identifies Combined AXL and JAK1 Inhibition as a Novel Therapeutic Strategy for Lung Cancer.Cancer Res2020
31989558Detection of DNA Methylation by MeDIP and MBDCap Assays: An Overview of Techniques.Methods Mol Biol2020
33053339PAI-1-Dependent Inactivation of SMAD4-Modulated Junction and Adhesion Complex in Obese Endometrial Cancer.Cell Rep2020
32971831Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism.Cancers (Basel)2020
32787954Modeling and analysis of Hi-C data by HiSIF identifies characteristic promoter-distal loops.Genome Med2020
32241278Comparative evaluation of network features for the prediction of breast cancer metastasis.BMC Med Genomics2020
32408897ERα-related chromothripsis enhances concordant gene transcription on chromosome 17q11.1-q24.1 in luminal breast cancer.BMC Med Genomics2020
32539762Age-associated genes in human mammary gland drive human breast cancer progression.Breast Cancer Res2020
27453286A novel algorithm for network-based prediction of cancer recurrence.Genomics2019
31805710Spatial EGFR Dynamics and Metastatic Phenotypes Modulated by Upregulated EphB2 and Src Pathways in Advanced Prostate Cancer.Cancers (Basel)2019
31303470A Non-canonical Role of YAP/TEAD Is Required for Activation of Estrogen-Regulated Enhancers in Breast Cancer.Mol Cell2019
30935961SOX11 hypermethylation as a tumor biomarker in endometrial cancer.Biochimie2019
30389702Adipokines Deregulate Cellular Communication via Epigenetic Repression of Gap Junction Loci in Obese Endometrial Cancer.Cancer Res2019
30659195Aberrant enhancer hypomethylation contributes to hepatic carcinogenesis through global transcriptional reprogramming.Nat Commun2019
29212856Tamoxifen Resistance in Breast Cancer Is Regulated by the EZH2-ERα-GREB1 Transcriptional Axis.Cancer Res2018
30036938BRCA1 Interacting Protein COBRA1 Facilitates Adaptation to Castrate-Resistant Growth Conditions.Int J Mol Sci2018
29955087miR-137 is a tumor suppressor in endometrial cancer and is repressed by DNA hypermethylation.Lab Invest2018
30003927Suppression of ribosomal protein RPS6KB1 by Nexrutine increases sensitivity of prostate tumors to radiation.Cancer Lett2018
29844167Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13.Proc Natl Acad Sci U S A2018
30306128Cross-talk among writers, readers, and erasers of m<sup>6</sup>A regulates cancer growth and progression.Sci Adv2018
29451304Distinct methylation profile of mucinous ovarian carcinoma reveals susceptibility to proteasome inhibitors.Int J Cancer2018
29233929Single-Cell RNA-seq Reveals a Subpopulation of Prostate Cancer Cells with Enhanced Cell-Cycle-Related Transcription and Attenuated Androgen Response.Cancer Res2018
27507616Integrated Epigenomics Analysis Reveals a DNA Methylation Panel for Endometrial Cancer Detection Using Cervical Scrapings.Clin Cancer Res2017
28082022Cellular cholesterol regulates monocyte deformation.J Biomech2017
28330931EGFR-Dependent Regulated Intramembrane Proteolysis of EpCAM-Response.Cancer Res2017
28402890Cholesterol Regulates Monocyte Rolling through CD44 Distribution.Biophys J2017
28288568Deep sequencing of HPV E6/E7 genes reveals loss of genotypic diversity and gain of clonal dominance in high-grade intraepithelial lesions of the cervix.BMC Genomics2017
28419278Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence.Nucleic Acids Res2017
28264810Promoter Methylation Modulates Indoleamine 2,3-Dioxygenase 1 Induction by Activated T Cells in Human Breast Cancers.Cancer Immunol Res2017
28938868START: a system for flexible analysis of hundreds of genomic signal tracks in few lines of SQL-like queries.BMC Genomics2017
29066347JAK2V617F influences epigenomic changes in myeloproliferative neoplasms.Biochem Biophys Res Commun2017
28809778Reprimo, a Potential p53-Dependent Tumor Suppressor Gene, Is Frequently Hypermethylated in Estrogen Receptor α-Positive Breast Cancer.Int J Mol Sci2017
28620196Integration of DNA methylation and gene transcription across nineteen cell types reveals cell type-specific and genomic region-dependent regulatory patterns.Sci Rep2017
  • 1 - 50 of 291

Recommended Authors

Hui Shen
Van Andel Institute
Career Start Year 2010
Number of shared co-authors 11
Suhn K Rhie
Keck School of Medicine of USC
Career Start Year 2009
Number of shared co-authors 5
Ritu Roy
University of California San Francisco.
Career Start Year 2007
Number of shared co-authors 1
Leander Van Neste
Maastricht University Medical Center
Career Start Year 2007
Number of shared co-authors 2
Katherine E Varley
Huntsman Cancer Institute
Career Start Year 2007
Number of shared co-authors 0
Yue Lu
The University of Texas MD Anderson Cancer Center
Career Start Year 2006
Number of shared co-authors 2
Yassen Assenov
German Cancer Research Center (DKFZ)
Career Start Year 2006
Number of shared co-authors 3
Andrew E Teschendorff
UCL Cancer Institute, University College London
Career Start Year 2005
Number of shared co-authors 5
Brock C Christensen
Geisel School of Medicine, Dartmouth College
Career Start Year 2005
Number of shared co-authors 2
David Klinkebiel
University of Nebraska Medical Center
Career Start Year 2005
Number of shared co-authors 0
Duncan Sproul
Institute of Genetics and Cancer, University of Edinburgh
Career Start Year 2004
Number of shared co-authors 0
Leslie Cope
Johns Hopkins University School of Medicine
Career Start Year 2003
Number of shared co-authors 2
Mathieu Lupien
Princess Margaret Cancer Research Centre
Career Start Year 2003
Number of shared co-authors 9
Jianmin Wang
Roswell Park Comprehensive Cancer Center
Career Start Year 2003
Number of shared co-authors 1
Howard H Yang
Center for Cancer Research, National Cancer Institute
Career Start Year 2002
Number of shared co-authors 0
Michael Slifker
Fox Chase Cancer Center
Career Start Year 2002
Number of shared co-authors 1
J??rg Tost
CEA-Institut de Biologie Francois Jacob, Universite Paris-Saclay
Career Start Year 2002
Number of shared co-authors 0
Sven Bilke
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 2001
Number of shared co-authors 2
Benjamin P Berman
Institute for Medical Research Israel-Canada, The Hebrew University of Jerusalem
Career Start Year 2000
Number of shared co-authors 3
Joyce E Ohm
Roswell Park Comprehensive Cancer Center
Career Start Year 1999
Number of shared co-authors 0
Michal R Schweiger
Institute for Translational Epigenetics, University of Cologne
Career Start Year 1999
Number of shared co-authors 1
Martin Hirst
University of British Columbia
Career Start Year 1998
Number of shared co-authors 4
Marina Bibikova
Departments of Bioinformatics and Clinical Genomics, Illumina Inc.
Career Start Year 1998
Number of shared co-authors 3
Martin Widschwendter
European Translational Oncology Prevention and Screening (EUTOPS) Institute
Career Start Year 1993
Number of shared co-authors 5
Holger Heyn
Barcelona Institute of Science and Technology, Spain Universitat Pompeu Fabra
Career Start Year 1988
Number of shared co-authors 2
Wan L Lam
British Columbia Cancer Research Institute
Career Start Year 1987
Number of shared co-authors 2
Jonathan R Pollack
Stanford University School of Medicine
Career Start Year 1987
Number of shared co-authors 2
Maxwell P Lee
National Cancer Institute, National Institutes of Health
Career Start Year 1986
Number of shared co-authors 1
Kornel E Schuebel
National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health
Career Start Year 1985
Number of shared co-authors 1
Peter W Laird
Van Andel Institute
Career Start Year 1985
Number of shared co-authors 9

Collaborators

Chun-Liang Chen
National Dong Hwa University
Co-authored papers 23
Lang Li
Harbin Medical University
Co-authored papers 17
Ramana V Davuluri
The Wistar Institute
Co-authored papers 14
Yidong Chen
The University of Texas Health Science Center at San Antonio
Co-authored papers 13
Christoph Plass
German Cancer Research Center
Co-authored papers 12
Ian M Thompson
CHRISTUS Santa Rosa Hospital-Medical Center
Co-authored papers 12
Sandya Liyanarachchi
The Ohio State University Comprehensive Cancer Center, Comprehensive Cancer Center
Co-authored papers 11
Aaron M Horning
Co-authored papers 8
Robert Brown
Ovarian Cancer Action Research Centre, Imperial College London
Co-authored papers 7
Fang Fang
Co-authored papers 7
Steven K Clinton
Comprehensive Cancer Center, The Ohio State University
Co-authored papers 6
Peggy J Farnham
Keck School of Medicine of USC
Co-authored papers 6
Changyu Shen
College of Materials Science and Engineering, Zhengzhou University
Co-authored papers 6
Michael A Liss
University of Texas Health San Antonio
Co-authored papers 6
Rong Li
University of Texas Health
Co-authored papers 5
Jean-Pierre J Issa
Fels Cancer Institute for Personalized Medicine, Temple University School of Medicine
Co-authored papers 5
Robin J Leach
University of Texas Health San Antonio
Co-authored papers 4
Zhao Zhang
Co-authored papers 4
Francisco A Perez
Seattle Children's Hospital
Co-authored papers 3
Haixu Tang
Indiana University
Co-authored papers 3
Jiaoti Huang
Duke University School of Medicine
Co-authored papers 3
Douglas B Rusch
Center for Genomics and Bioinformatics, Indiana University
Co-authored papers 3
Michael C Ostrowski
Hollings Cancer Center, Medical University of South Carolina
Co-authored papers 2
Linda Z Penn
University of Toronto
Co-authored papers 2
Jenny Chang-Claude
German Cancer Research Center (DKFZ)
Co-authored papers 2
Louise C Showe
The Wistar Institute
Co-authored papers 2
Yan Liu
Chengdu Medical College
Co-authored papers 2
Peter J Houghton
The University of Texas Health Science Center at San Antonio
Co-authored papers 2
Simon Tavar??
Irving Institute for Cancer Dynamics, Columbia University
Co-authored papers 2
Cun-Yu Wang
University of California, Los Angeles (university of california los angeles)
Co-authored papers 2
Release 1.2